ATE78467T1 - Kondensierte benzazepine. - Google Patents

Kondensierte benzazepine.

Info

Publication number
ATE78467T1
ATE78467T1 AT87906614T AT87906614T ATE78467T1 AT E78467 T1 ATE78467 T1 AT E78467T1 AT 87906614 T AT87906614 T AT 87906614T AT 87906614 T AT87906614 T AT 87906614T AT E78467 T1 ATE78467 T1 AT E78467T1
Authority
AT
Austria
Prior art keywords
benzazepines
condensed
useful
hypertension
isomer
Prior art date
Application number
AT87906614T
Other languages
English (en)
Inventor
Joel Gilbert Berger
Wei Kong Chang
Elijah Herman Gold
John Welch Clader
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE78467T1 publication Critical patent/ATE78467T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT87906614T 1987-07-15 1987-07-15 Kondensierte benzazepine. ATE78467T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP87906614A EP0363353B1 (de) 1987-07-15 1987-07-15 Kondensierte benzazepine
PCT/US1987/001636 WO1989000561A1 (en) 1987-07-15 1987-07-15 Fused benzazepines
EP87110253A EP0299101B1 (de) 1987-07-15 1987-07-16 Kondensierte Benzazepine

Publications (1)

Publication Number Publication Date
ATE78467T1 true ATE78467T1 (de) 1992-08-15

Family

ID=26108265

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87906614T ATE78467T1 (de) 1987-07-15 1987-07-15 Kondensierte benzazepine.

Country Status (13)

Country Link
EP (2) EP0363353B1 (de)
JP (1) JPH0678317B2 (de)
AT (1) ATE78467T1 (de)
AU (1) AU617651B2 (de)
DE (1) DE3780649T2 (de)
DK (1) DK162889C (de)
ES (1) ES2043623T3 (de)
FI (1) FI93212C (de)
GR (1) GR3006671T3 (de)
HU (1) HU203537B (de)
NO (1) NO177264C (de)
WO (1) WO1989000561A1 (de)
ZA (1) ZA875183B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
PL168408B1 (pl) * 1989-08-03 1996-02-29 Smithkline Beecham Biolog Sposób wytwarzania stransformowanego mikroorganizmu PL
CA2075181C (en) * 1990-02-02 1997-12-09 Theodros Asberom 4,5-bridged-2,3,4,5-tetrahydro-1h-3-benzazepine-7-ols
JPH07137816A (ja) * 1993-11-15 1995-05-30 Tokai Univ 地下空洞内貯蔵装置
MXPA05002249A (es) * 2002-08-29 2005-06-08 Schering Corp Antagonistas selectivos del receptor d1/d5 para el tratamiento de obesidad y trastornos del sistema nervioso central.
JP2006526021A (ja) * 2003-05-22 2006-11-16 シェーリング　コーポレイション 肥満およびｃｎｓ障害を治療する選択的ｄ１／ｄ５レセプタアンタゴニストとしての５ｈ−ベンゾ［ｄ］ナフト［２，１−ｂ］アゼピン誘導体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
WO1987004430A2 (en) * 1986-01-16 1987-07-30 Schering Corporation Fused benzazepines

Also Published As

Publication number Publication date
FI900175A0 (fi) 1990-01-12
NO900186L (no) 1990-01-12
DE3780649T2 (de) 1992-12-10
GR3006671T3 (de) 1993-06-30
DK9390D0 (da) 1990-01-12
JPH0678317B2 (ja) 1994-10-05
JPH02504629A (ja) 1990-12-27
EP0299101A1 (de) 1989-01-18
FI93212C (fi) 1995-03-10
DK162889C (da) 1992-05-11
WO1989000561A1 (en) 1989-01-26
DK9390A (da) 1990-03-12
DE3780649D1 (de) 1992-08-27
NO177264B (no) 1995-05-08
NO177264C (no) 1995-08-16
EP0363353B1 (de) 1992-07-22
NO900186D0 (no) 1990-01-12
DK162889B (da) 1991-12-23
AU8037887A (en) 1989-02-13
ZA875183B (en) 1988-04-08
HU203537B (en) 1991-08-28
FI93212B (fi) 1994-11-30
EP0363353A1 (de) 1990-04-18
EP0299101B1 (de) 1992-09-23
AU617651B2 (en) 1991-12-05
ES2043623T3 (es) 1994-01-01

Similar Documents

Publication Publication Date Title
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
PL348237A1 (en) Fused 1,2,4-thiadiazine derivatives, their preparation and use
WO1987004430A3 (en) Fused benzazepines
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
ATE44650T1 (de) Arzneimittel, enthaltend eine kombination von nitrendipin mit enalapril, und verfahren zu seiner herstellung.
NO20013941D0 (no) Polynukleotider med forkortet kjede og fremgangsmate ved fremstillingen derav
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
ES2043623T3 (es) Benzazepinas condensadas.
SG47623A1 (en) 2-aryl-5-(trifluoromethyl) -2-pyrroline compounds and process for the manufacture of insecticidal 2-aryl-1- (alkoxymethyl)-4-halo-5-(trifluoromethyl) pyrroles
DE69300551T2 (de) Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid.
DK0906255T3 (da) Fremgangsmåde til fremstilling af enantiomert ren azetidin-2-carboxylsyre
DK598687D0 (da) Detergentkomposition
DE69012882D1 (de) Herstellung von Stickstoffzusammensetzungen.
DE69425405D1 (de) Verbessertes Verfahren zur Herstellung von 2,4-di(alkylamine)-6-alkylthio-s-Triazinen und 2,4-alkylamine-4,6-di(alkylthio)-s-Triazinen
ATE116320T1 (de) 5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin 6-one und -thione und deren verwendung bei der vorbeugung und und behandlung von aids.
DE59812284D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
ES549982A0 (es) Procedimiento para preparar 6-sustituido-5-feniltetrazol (1,5-a)-(1,2,4)triazol-(1,5-c)pirimidinas
DE69802312T2 (de) Verfahren zur Herstellung von 3,3',5,5'-Tetra-b-Butylbiphenol
DE58906998D1 (de) Verfahren zur Herstellung von 4,5,6-Trichlorpyrimidin.
DE59109226D1 (de) Verfahren zur Herstellung von 5-Chlorcarbonyl-5H-dibenz/b,f/azepin
DE3854027D1 (de) Verfahren zur Herstellung von Pyrazolo [5,1-b] chinazolonen.
DE69431706T2 (de) Verfahren zur Herstellung von 5-Amino-dihydropyrrol, Zwischenprodukt davon und Verfahren zur Herstellung des Zwischenprodukts
FR2650588B1 (fr) Nouveaux derives de la methylidene-2 pyrrolidine, leurs procedes de fabrication, et leur application comme precurseurs chimiques des pyrroles
EP0412941A3 (en) Phospholipids for the treatment of multiple sclerosis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee